New pill aims to shrink tumors in advanced breast and ovarian cancers
NCT ID NCT05735080
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study tests a new daily pill, INX-315, in 150 people with advanced breast, ovarian, or other solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control tumors. The study includes three parts: testing the drug alone, with another hormone therapy, or with a combination of two other cancer drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact Email: •••••@•••••
-
Duke Cancer Center/ DUMC
RECRUITINGDurham, North Carolina, 27705, United States
Contact
-
Emory Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Florida Cancer Specialists
RECRUITINGOrlando, Florida, 32827, United States
Contact
Contact Email: •••••@•••••
-
Fort Wayne Medical Oncology and Hematology
RECRUITINGFort Wayne, Indiana, 46804, United States
Contact Email: •••••@•••••
Contact
-
Gabrail Cancer Research Center
RECRUITINGCanton, Ohio, 44718, United States
Contact Email: •••••@•••••
Contact
-
Georgia Cancer Center at Augusta University
RECRUITINGAugusta, Georgia, 30912, United States
Contact Email: •••••@•••••
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Levine Cancer Institute (LCI)- Atrium Health
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
-
Mater Hospital
RECRUITINGSouth Brisbane, 4101, Australia
Contact
-
Next Oncology
RECRUITINGDallas, Texas, 75039, United States
Contact Email: •••••@•••••
Contact
-
Next Oncology
RECRUITINGHouston, Texas, 77054, United States
Contact Email: •••••@•••••
Contact
-
Northwest Medical Specialties, PLLC
RECRUITINGTacoma, Washington, 98405, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oncology Consultants
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peninsula and South Eastern Haematology & Oncology Group
RECRUITINGFrankston, Victoria, 3199, Australia
Contact Email: •••••@•••••
Contact
-
Peter MacCallum Cancer Center
RECRUITINGParkville, Victoria, 3052, Australia
Contact
Contact Email: •••••@•••••
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UTSW Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.